Journal profile · Medicine-Nephrology
Glomerular Diseases
ISSN 2673-3633 · Karger Publishers · Switzerland
Glomerular Diseases: fully open access; APC about USD 1,080; median 95 days to acceptance (74 articles, last 24 months); 45 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Glomerular Diseases is published by Karger Publishers. By OpenAlex counts of its recent articles, its largest topics are Renal Diseases and Glomerulopathies, Vasculitis and related conditions and Chronic Kidney Disease and Diabetes, together about 66.3% of its articles. Its main subfields are Nephrology. (generated from OpenAlex topic counts and CAS ranking data)
Glomerular Diseases is a first-in-class open-access journal focusing exclusively on the glomerulus. Its overarching purpose is to disseminate cutting-edge clinical knowledge and expertise coupled with innovation in enhanced morphological capture, genomics, molecular signatures, epigenetics, machine learning, and statistical analytics in order to accomplish precision medicine for patients with glomerular diseases. It will serve the international community of academicians, clinicians, clinical trialists, patients, and patient-centered organizations. Glomerular Diseases, as a forum for frontline clinical, basic, and informatics science as well as clinical practice, ultimately aims to improve patient care. Glomerular Diseases welcomes review articles and original research in the fields of clinical nephrology, renal pathology, analytical biostatistics, bioinformatics methods and their applications, as well as in basic science, genetics, genomics, proteomics, and biomarker discovery. The journal includes a patient-focused corner and publishes editorial and opinion pieces.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Nephrology
Editor-in-chief Sharon G. AdlerPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Renal Diseases and GlomerulopathiesMedicine34%
- Vasculitis and related conditionsMedicine17.5%
- Chronic Kidney Disease and DiabetesMedicine14.8%
- Systemic Lupus Erythematosus ResearchMedicine10.1%
- Renal Transplantation Outcomes and TreatmentsMedicine4.7%
- Complement system in diseasesImmunology and Microbiology4.5%
- Dialysis and Renal Disease ManagementMedicine2.1%
- Acute Kidney Injury ResearchMedicine1.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Nephrology | Q2 | 43/88 | 51st |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.9LetPub ·
- CiteScore (publisher)
- 2.9Publisher website ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 16OpenAlex ·
- i10-index
- 25OpenAlex ·
- 2-year mean citedness
- 2.27OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 196 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 33 | 33 | 286 |
| 2025 | 45 | 45 | 302 |
| 2024 | 30 | 30 | 185 |
| 2023 | 26 | 26 | 90 |
| 2022 | 22 | 22 | 40 |
| 2021 | 39 | 39 | 9 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
95 daysMedian, submission to acceptance · P25–P75 67 days – 140 days
- Acceptance to online
- median 14 days (74 articles)
- Submission to online
- median 115 days
- Sample
- 74 articles with submission and acceptance dates (76 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 24 weeksLetPub ·
- Submission to first decision
- 35 daysPublisher website ·
- Submission to final decision
- 77 daysPublisher website ·
- Submission to publication (journal-reported)
- about 24 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 930 / USD 1,080 / CHF 980 | No | CC BY, CC BY-NC | |
| OpenAlex | USD 990 / EUR 850 / CHF 920 | — | — | |
| LetPub | EUR 930 / USD 1,080 / CHF 980 | No | — | |
| Publisher website | USD 1,230 / USD 980 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare3 items from the author guidelines
- Keywords
- ≥ 3
- Reference style
- Vancouver
- Graphical abstract
- Required
Article types accepted12, with length limits
- brief reportailable below. For guidance purposes, a Brief Report is typically 3000 words in length and up to 3 Tables and Figures. Document Brief Remain text ≤ 3,000 words
- case reportailable below. For guidance purposes, a Case Report is typically 2500 words in length and up to 3 Tables and Figures. Authors may submimain text ≤ 2,500 words
- commentaryailable below. For guidance purposes, a Commentary is typically 1000 words in length and up to 3 Tables and Figures. Document Commentamain text ≤ 1,000 words
- editorialilable below. For guidance purposes, an Editorial is typically 1000 words in length and up to 3 Tables and Figures. Document Editoriamain text ≤ 1,000 words
- letterailable below. For guidance purposes, a Letter is typically 1000 words in length and up to 3 Tables and Figures. Document Letter Cmain text ≤ 1,000 words
- methods articleailable below. For guidance purposes, a Methods Article is typically 3000 words in length and up to 3 Tables and Figures. Documents Methodsmain text ≤ 3,000 words
- opinion piecespublishes editorial and opinion piecesLength not stated
- original researchGlomerular Diseases welcomes review articles and original researchLength not stated
- research articleailable below. For guidance purposes, a Research Article is typically 5000 words in length with 4 to 8 Tables and Figures. - Quality Improvemain text ≤ 5,000 words
- review articleailable below. For guidance purposes, a Review Article is typically 5000 words in length with 4 to 8 Tables and Figures. Document Review Amain text ≤ 5,000 words
- review articlesGlomerular Diseases welcomes review articles and original researchLength not stated
- systematic reviewailable below. For guidance purposes, a Systematic Review is typically 5000 words in length with 4 to 8 Tables and Figures. Document Systematmain text ≤ 5,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Self-archiving
- Authorship Author Contributions
In the Author Contribution statement, a short statement detailing the contributions of each person named as an author should be included. The CRediT taxonomy is a useful framework for preparing this section. Contributors to the submission who do not fulfil the ICMJE Criteria for Authorship should be credited, with their consent, in the Acknowledgement section.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors are required to disclose any relationship that could be perceived as a conflict of interest in the Conflict of Interest Statement. All forms of support and financial involvement which took place in the previous three years should be listed, regardless of their potential relevance to the paper. Nonfinancial relationships that may potentially influence the writing of the manuscript should al…
Source ↗Publisher website ·- Data availability Data Availability Statement
Data Availability Statement Model summary
Authors are required to provide a Data Availability Statement that details whether data are publicly available and where the data supporting their study can be accessed. The journal’s data sharing policy strongly encourages authors to make all datasets on which the conclusions of the paper rely available to editors, reviewers and readers without unnecessary restriction wherever possible. In cases …
Source ↗Publisher website ·- Publication ethics
Statement of Ethics Model summary
The Statement of Ethics must provide detail about the ethical approval process for the study reported in the manuscript, including the name and affiliation of the committee who approved the study and the decision reference number.
Source ↗Publisher website ·- License & copyright Licenses and Copyright
Licenses and Copyright Model summary
Articles published in Glomerular Diseases are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, unless otherwise agreed with Karger Publishers. When sharing or reusing any article, attribution must be given to the original source, using the statement "The final, published version of this article is available at http://karger.com/?doi=[insert DO…
Source ↗Publisher website ·- Open access Open Access
Open Access (All articles are published under Creative Commons licenses)
Source ↗Publisher website ·- Peer review Peer Review
Peer Review Type and Process Model summary
Peer Review Policy All Karger journals employ a rigorous peer-review process to confirm the validity and ensure scientific accuracy of published articles. Independent researchers with relevant expertise assess submitted manuscripts to help journal editors determine whether a manuscript should be published in their journal. All articles, except for Editorials and some Correspondence articles, are e…
Source ↗Publisher website ·- Self-archiving Archiving and Self-Archiving
All articles are archived in Portico. Articles may also be archived in PubMed Central if the journal is indexed there. Karger permits authors of Open Access articles to post the Version of Record (VOR) of their articles in Open Access repositories or on other websites. Preprints may be shared without restriction. Re-posted Open Access articles must follow the terms of the relevant Creative Commons…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Karger Publishers
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2673-3633
- Print ISSN
- 2673-3625
- Latest issue on the website
- Volume 6, Issue 1 (December 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Glomerular Diseases
How long does peer review take at Glomerular Diseases?
Based on the dates recorded on 74 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 95 days (interquartile range 67–140 days); authors report an average review time of about 24 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Glomerular Diseases?
According to the journal's author guidelines: Keywords: ≥ 3; Reference style: Vancouver; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Glomerular Diseases?
According to LetPub and DOAJ records, Glomerular Diseases is indexed in Scopus and DOAJ. The journal's website also lists PMC; that list has not been checked against each database.
Is Glomerular Diseases open access, and what is the APC?
Glomerular Diseases is a fully open-access journal. APC about USD 1,080.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .